Search

Lithium citrate

Bupranolol

Bupranolol is a non-selective beta blocker with potency similar to [propanolol]. It does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.

Phenoxyethanol

It is very easy to use in various types of formulations and is chemically stable. … It has also been used in vaccines and shown to inactivate bacteria, and several types of yeast [A32838].

Clobetasol propionate

[L11815] It has demonstrated superior activity compared to [fluocinonide][A190963] and was first described in the literature in 1974.

Methaqualone

Methaqualone is a sedative-hypnotic drug that is similar in effect to barbiturates, a general central nervous system depressant. … The sedative-hypnotic activity was first noted by Indian researchers in the 1950s and in 1962 methaqualone itself was patented in the US by Wallace and Tiernan.

Imidafenacin

It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. … It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical.

Pranlukast

It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.

Oxcarbazepine

to its primarily reductive metabolism. … [A186011] Compared to other anti-epileptic drugs, which are generally metabolized via the cytochrome P450 system, oxcarbazepine has a reduced propensity for involvement in drug-drug interactions owing

Bromothalonil

In 2005, MDBGN was named in the top 15 most frequently positive allergens identified in patch tests by the North American Contact Dermatitis Group (NACDG)[A34326]. … Sensitivity to Bromothalonil may be identified with a clinical patch test.

Raxibacumab

Raxibacumab is produced by recombinant DNA technology in a murine cell expression system. FDA approved on December 14, 2012.